_id

691058acccc777a4e85d5708

Ticker

CYTK

Name

Cytokinetics Inc

Exchange

NASDAQ

Address

350 Oyster Point Boulevard, South San Francisco, CA, United States, 94080

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.cytokinetics.com

Description

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure. It also develops CK- 089, a fast skeletal muscle troponin activator that is in Phase I clinical trial; CK-586, a small molecule cardiac myosin inhibitor, that is in Phase II clinical trial; and aficamten, a novel, oral, small molecule cardiac myosin inhibitor which is in Phase III clinical trial discovered for the treatment of hypertrophic cardiomyopathy. It has a strategic alliance with Ji Xing Pharmaceuticals Limited; and a collaboration and license agreement for the development and commercialization of aficamten in Japan for the treatment of patients with obstructive and non-obstructive hypertrophic cardiomyopathy. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Last Close

60.77

Volume

525375

Current Price

63.35

Change

4.245515879545826

Last Updated

2025-11-29T12:05:50.278Z

Image

-

Ipo Date

2004-04-29T00:00:00.000Z

Market Cap

8329909248

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.31671166666666667

Sentiment Sources

60

Rating

4.2857

Target Price

78.4444

Strong Buy

9

Buy

9

Hold

3

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

1936000

Cost Of Revenue

2679000

Gross Profit

-743000

Operating Expenses

166012000

Operating Income

-166755000

Interest Expense

26322000

Pretax Income

-306178000

Net Income

-306178000

Eps

-2.551866113250321

Dividends Per Share

-

Shares Outstanding

122264929

Income Tax Expense

-

EBITDA

-277177000

Operating Margin

-8613.378099173553

Total Other Income Expense Net

-139423000

Cash

225467000

Short Term Investments

737068000

Receivables

1808000

Inventories

-

Total Current Assets

977349000

Property Plant Equipment

153581000

Total Assets

1436557000

Payables

22084000

Short Term Debt

37927000

Long Term Debt

1048271000

Total Liabilities

1957680000

Equity

-521123000

Depreciation

2679000

Change In Working Capital

22531000

Cash From Operations

-107505000

Capital Expenditures

9354000

Cash From Investing

-70979000

Cash From Financing

330466000

Net Change In Cash

152028000

PE

-

PB

-14.58553873077949

ROE

58.75349965363264

ROA

-21.313320668793512

FCF

-116859000

Fcf Percent

-60.36105371900826

Piotroski FScore

1

Health Score

31

Deep Value Investing Score

0.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

6.3

Garp Investing Score

2.5

Growth Investing Score

2.5

Momentum Investing Score

5

Net Net Investing Score

0.5

Quality Investing Score

2.5

Value Investing Score

2.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

1936000

Quarters > 0 > income Statement > cost Of Revenue

2679000

Quarters > 0 > income Statement > gross Profit

-743000

Quarters > 0 > income Statement > operating Expenses

166012000

Quarters > 0 > income Statement > operating Income

-166755000

Quarters > 0 > income Statement > interest Expense

26322000

Quarters > 0 > income Statement > pretax Income

-306178000

Quarters > 0 > income Statement > net Income

-306178000

Quarters > 0 > income Statement > eps

-2.551866113250321

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

119982000

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-277177000

Quarters > 0 > income Statement > operating Margin

-8613.378099173553

Quarters > 0 > income Statement > total Other Income Expense Net

-139423000

Quarters > 0 > balance Sheet > cash

225467000

Quarters > 0 > balance Sheet > short Term Investments

737068000

Quarters > 0 > balance Sheet > receivables

1808000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

977349000

Quarters > 0 > balance Sheet > property Plant Equipment

153581000

Quarters > 0 > balance Sheet > total Assets

1436557000

Quarters > 0 > balance Sheet > payables

22084000

Quarters > 0 > balance Sheet > short Term Debt

37927000

Quarters > 0 > balance Sheet > long Term Debt

1048271000

Quarters > 0 > balance Sheet > total Liabilities

1957680000

Quarters > 0 > balance Sheet > equity

-521123000

Quarters > 0 > cash Flow > net Income

-306178000

Quarters > 0 > cash Flow > depreciation

2679000

Quarters > 0 > cash Flow > change In Working Capital

22531000

Quarters > 0 > cash Flow > cash From Operations

-107505000

Quarters > 0 > cash Flow > capital Expenditures

9354000

Quarters > 0 > cash Flow > cash From Investing

-70979000

Quarters > 0 > cash Flow > cash From Financing

330466000

Quarters > 0 > cash Flow > net Change In Cash

152028000

Quarters > 0 > ratios > PE

-2.551866113250321

Quarters > 0 > ratios > PB

-14.58553873077949

Quarters > 0 > ratios > ROE

58.75349965363264

Quarters > 0 > ratios > ROA

-21.313320668793512

Quarters > 0 > ratios > FCF

-116859000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-60.36105371900826

Quarters > 0 > health Score

31

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

66769000

Quarters > 1 > income Statement > cost Of Revenue

2285000

Quarters > 1 > income Statement > gross Profit

64483999

Quarters > 1 > income Statement > operating Expenses

175990000

Quarters > 1 > income Statement > operating Income

-111506000

Quarters > 1 > income Statement > interest Expense

24265000

Quarters > 1 > income Statement > pretax Income

-134370000

Quarters > 1 > income Statement > net Income

-134370000

Quarters > 1 > income Statement > eps

-1.1248399005499887

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

119457000

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-107820000

Quarters > 1 > income Statement > operating Margin

-167.00265093082118

Quarters > 1 > income Statement > total Other Income Expense Net

-22864000

Quarters > 1 > balance Sheet > cash

74940000

Quarters > 1 > balance Sheet > short Term Investments

783195000

Quarters > 1 > balance Sheet > receivables

8410000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

886542000

Quarters > 1 > balance Sheet > property Plant Equipment

146339000

Quarters > 1 > balance Sheet > total Assets

1225635000

Quarters > 1 > balance Sheet > payables

16228000

Quarters > 1 > balance Sheet > short Term Debt

33985000

Quarters > 1 > balance Sheet > long Term Debt

713045000

Quarters > 1 > balance Sheet > total Liabilities

1594355000

Quarters > 1 > balance Sheet > equity

-368720000

Quarters > 1 > cash Flow > net Income

-134370000

Quarters > 1 > cash Flow > depreciation

2285000

Quarters > 1 > cash Flow > change In Working Capital

-51111000

Quarters > 1 > cash Flow > cash From Operations

-128236000

Quarters > 1 > cash Flow > capital Expenditures

4145000

Quarters > 1 > cash Flow > cash From Investing

52881000

Quarters > 1 > cash Flow > cash From Financing

78533000

Quarters > 1 > cash Flow > net Change In Cash

2496000

Quarters > 1 > ratios > PE

-1.1248399005499887

Quarters > 1 > ratios > PB

-20.523977408331525

Quarters > 1 > ratios > ROE

36.442286830114995

Quarters > 1 > ratios > ROA

-10.963296576876475

Quarters > 1 > ratios > FCF

-132381000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-1.9826715990953885

Quarters > 1 > health Score

31

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

1579000

Quarters > 2 > income Statement > cost Of Revenue

99841000

Quarters > 2 > income Statement > gross Profit

-98262000

Quarters > 2 > income Statement > operating Expenses

57369000

Quarters > 2 > income Statement > operating Income

-155631000

Quarters > 2 > income Statement > interest Expense

22946000

Quarters > 2 > income Statement > pretax Income

-161376000

Quarters > 2 > income Statement > net Income

-161376000

Quarters > 2 > income Statement > eps

-1.361868755063462

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

118496000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-136130000

Quarters > 2 > income Statement > operating Margin

-9856.301456618112

Quarters > 2 > income Statement > total Other Income Expense Net

-5745000

Quarters > 2 > balance Sheet > cash

73680000

Quarters > 2 > balance Sheet > short Term Investments

864538000

Quarters > 2 > balance Sheet > receivables

2012000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

956053000

Quarters > 2 > balance Sheet > property Plant Equipment

144614000

Quarters > 2 > balance Sheet > total Assets

1264051000

Quarters > 2 > balance Sheet > payables

13942000

Quarters > 2 > balance Sheet > short Term Debt

32534000

Quarters > 2 > balance Sheet > long Term Debt

645168000

Quarters > 2 > balance Sheet > total Liabilities

1530464000

Quarters > 2 > balance Sheet > equity

-266413000

Quarters > 2 > cash Flow > net Income

-161376000

Quarters > 2 > cash Flow > depreciation

2300000

Quarters > 2 > cash Flow > change In Working Capital

-5203000

Quarters > 2 > cash Flow > cash From Operations

-131616999

Quarters > 2 > cash Flow > capital Expenditures

5664000

Quarters > 2 > cash Flow > cash From Investing

105956000

Quarters > 2 > cash Flow > cash From Financing

4754000

Quarters > 2 > cash Flow > net Change In Cash

-21177000

Quarters > 2 > ratios > PE

-1.361868755063462

Quarters > 2 > ratios > PB

-28.17700938017289

Quarters > 2 > ratios > ROE

60.57362065664964

Quarters > 2 > ratios > ROA

-12.766573500594516

Quarters > 2 > ratios > FCF

-137280999

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-86.94173464217859

Quarters > 2 > health Score

31

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

16927000

Quarters > 3 > income Statement > cost Of Revenue

93629000

Quarters > 3 > income Statement > gross Profit

-76702000

Quarters > 3 > income Statement > operating Expenses

62338000

Quarters > 3 > income Statement > operating Income

-139040000

Quarters > 3 > income Statement > interest Expense

22594000

Quarters > 3 > income Statement > pretax Income

-150020000

Quarters > 3 > income Statement > net Income

-150020000

Quarters > 3 > income Statement > eps

-1.2705483802667796

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

118075000

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-125043000

Quarters > 3 > income Statement > operating Margin

-821.4095823240976

Quarters > 3 > income Statement > total Other Income Expense Net

-10980000

Quarters > 3 > balance Sheet > cash

94857000

Quarters > 3 > balance Sheet > short Term Investments

981157000

Quarters > 3 > balance Sheet > receivables

16650000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

1107940000

Quarters > 3 > balance Sheet > property Plant Equipment

140973000

Quarters > 3 > balance Sheet > total Assets

1401673000

Quarters > 3 > balance Sheet > payables

20369000

Quarters > 3 > balance Sheet > short Term Debt

30498000

Quarters > 3 > balance Sheet > long Term Debt

645597000

Quarters > 3 > balance Sheet > total Liabilities

1537045000

Quarters > 3 > balance Sheet > equity

-135372000

Quarters > 3 > cash Flow > net Income

-150020000

Quarters > 3 > cash Flow > depreciation

2383000

Quarters > 3 > cash Flow > change In Working Capital

41714000

Quarters > 3 > cash Flow > cash From Operations

-65569999

Quarters > 3 > cash Flow > capital Expenditures

1290000

Quarters > 3 > cash Flow > cash From Investing

110863000

Quarters > 3 > cash Flow > cash From Financing

2384000

Quarters > 3 > cash Flow > net Change In Cash

47969000

Quarters > 3 > ratios > PE

-1.2705483802667796

Quarters > 3 > ratios > PB

-55.25552736164051

Quarters > 3 > ratios > ROE

110.82055373341606

Quarters > 3 > ratios > ROA

-10.702924291186317

Quarters > 3 > ratios > FCF

-66859999

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-3.9499024635198206

Quarters > 3 > health Score

31

Valuation > metrics > PE

-2.551866113250321

Valuation > metrics > PB

-14.58553873077949

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > metrics > ROE

58.75349965363264

Profitability > metrics > ROA

-31.32739686642131

Profitability > metrics > Net Margin

-158.14979338842974

Profitability > final Score

40

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

-6.3351948940050145

Risk > final Score

5

Risk > verdict

High

Liquidity > metrics > Current Ratio

16.286164203229408

Liquidity > metrics > Quick Ratio

16.286164203229408

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

50

Prev Valuations > 1

50

Prev Valuations > 2

50

Prev Profitabilities > 0

40

Prev Profitabilities > 1

40

Prev Profitabilities > 2

40

Prev Risks > 0

12

Prev Risks > 1

3

Prev Risks > 2

5

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:23:03.288Z